|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 27043 |
FusionGeneSummary for PHYKPL_STMN1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: PHYKPL_STMN1 | Fusion gene ID: 27043 | Hgene | Tgene | Gene symbol | PHYKPL | STMN1 | Gene ID | 85007 | 3925 |
| Gene name | 5-phosphohydroxy-L-lysine phospho-lyase | stathmin 1 | |
| Synonyms | AGXT2L2|PHLU | C1orf215|LAP18|Lag|OP18|PP17|PP19|PR22|SMN | |
| Cytomap | 5q35.3 | 1p36.11 | |
| Type of gene | protein-coding | protein-coding | |
| Description | 5-phosphohydroxy-L-lysine phospho-lyase5-phosphonooxy-L-lysine phospho-lyasealanine--glyoxylate aminotransferase 2-like 2 | stathminleukemia-associated phosphoprotein p18metablastinoncoprotein 18phosphoprotein 19phosphoprotein p19prosolinstathmin 1/oncoprotein 18testicular tissue protein Li 189transmembrane protein C1orf215 | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q8IUZ5 | P16949 | |
| Ensembl transtripts involved in fusion gene | ENST00000308158, ENST00000481811, ENST00000476170, | ENST00000426559, ENST00000455785, ENST00000399728, ENST00000465604, ENST00000357865, ENST00000374291, | |
| Fusion gene scores | * DoF score | 4 X 4 X 1=16 | 5 X 5 X 4=100 |
| # samples | 5 | 5 | |
| ** MAII score | log2(5/16*10)=1.64385618977472 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(5/100*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: PHYKPL [Title/Abstract] AND STMN1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | STMN1 | GO:0007019 | microtubule depolymerization | 9880330 |
| Tgene | STMN1 | GO:0007052 | mitotic spindle organization | 9271428 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AK123488 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000308158 | ENST00000426559 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000308158 | ENST00000455785 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000308158 | ENST00000399728 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-5UTR | ENST00000308158 | ENST00000465604 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000308158 | ENST00000357865 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000308158 | ENST00000374291 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000481811 | ENST00000426559 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000481811 | ENST00000455785 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000481811 | ENST00000399728 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-5UTR | ENST00000481811 | ENST00000465604 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000481811 | ENST00000357865 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000481811 | ENST00000374291 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000476170 | ENST00000426559 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000476170 | ENST00000455785 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000476170 | ENST00000399728 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-5UTR | ENST00000476170 | ENST00000465604 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000476170 | ENST00000357865 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
| intron-intron | ENST00000476170 | ENST00000374291 | PHYKPL | chr5 | 177653443 | - | STMN1 | chr1 | 26228239 | - |
Top |
FusionProtFeatures for PHYKPL_STMN1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| PHYKPL | STMN1 |
| Catalyzes the pyridoxal-phosphate-dependent breakdown of5-phosphohydroxy-L-lysine, converting it to ammonia, inorganicphosphate and 2-aminoadipate semialdehyde.{ECO:0000269|PubMed:22241472}. | Involved in the regulation of the microtubule (MT)filament system by destabilizing microtubules. Prevents assemblyand promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis.Involved in the control of the learned and innate fear (Bysimilarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PHYKPL_STMN1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PHYKPL_STMN1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PHYKPL_STMN1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | PHYKPL | Q8IUZ5 | DB00114 | Pyridoxal Phosphate | 5-phosphohydroxy-L-lysine phospho-lyase | small molecule | approved|investigational|nutraceutical |
Top |
RelatedDiseases for PHYKPL_STMN1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | PHYKPL | C3554344 | PHOSPHOHYDROXYLYSINURIA | 1 | UNIPROT |
| Tgene | STMN1 | C0011570 | Mental Depression | 3 | PSYGENET |
| Tgene | STMN1 | C0011581 | Depressive disorder | 3 | PSYGENET |
| Tgene | STMN1 | C0017638 | Glioma | 1 | CTD_human |
| Tgene | STMN1 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
| Tgene | STMN1 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
| Tgene | STMN1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| Tgene | STMN1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|